An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis.
C
C
Leport
S
S
Bastuji-Garin
C
C
Perronne
D
D
Salmon
C
C
Marche
F
F
Briçaire
J L
JL
Vilde
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D001927:Brain Diseases / Q000188:drug therapy* / Q000209:etiology; D002981:Clindamycin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D011739:Pyrimethamine / Q000627:therapeutic use*; D014123:Toxoplasmosis / Q000188:drug therapy* / Q000209:etiology
D002981:Clindamycin; D011739:Pyrimethamine